Oxygen to Relieve Dyspnoea in Non-hypoxaemic Patients with End-stage Heart Failure

Phase 3

• Conditions: Heart failure; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12609000103268
• Lead Sponsor: Curtin University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-02-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 285

Inclusion Criteria

Heart failure of either systolic or diastolic aetiology classified by New York Heart Association Class III-IV

Receiving optimal therapy or documented intolerance/trial (as outlined by the Chronic Heart failure guidelines developed by the Cardiac Society of Australia and new Zealand and the National Heart Foundation

History of two or more presentations to hospital within the previous six months with heart failure as the primary diagnosis.

Exclusion Criteria

Unable or unwilling to give informed consent
Not investigated for reversible causes of heart failure (HF)
Undergoing current treatment for sleep disorder breathing
Significant cognitive impairment and/or dementia
PaCO2 > 45mmHg on room air
Eligible for domiciliary oxygen under current funding guidelines
Resident in residential aged care facility
Current smokers

Study & Design

• Study Type: Interventional
• Study Design: Not specified